115 related articles for article (PubMed ID: 6439005)
1. Monoclonal IgM-secreting neoplasms. Clinical and morphologic heterogeneity.
Nakamine H; Takenaka T; Nishino E; Maeda J; Nishihara T; Saito K; Yabumoto M; Umemoto M; Masuyama Y; Honda H
Acta Pathol Jpn; 1984 Sep; 34(5):1147-56. PubMed ID: 6439005
[TBL] [Abstract][Full Text] [Related]
2. [Morphologic manifestations of Waldenström's disease].
Diebold J; Reynes M; Kalifat R; Tricot G
Sem Hop; 1975 Dec; 51(48):2927-34. PubMed ID: 175504
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins on the surface of lymphoid cells in Waldenström's macroglobulinemia.
Preud'homme JL; Seligmann M
J Clin Invest; 1972 Mar; 51(3):701-5. PubMed ID: 4622108
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow histology in monoclonal macroglobulinemia.
Rywlin AM; Civantos F; Ortega RS; Dominguez CJ
Am J Clin Pathol; 1975 Jun; 63(6):769-78. PubMed ID: 807098
[TBL] [Abstract][Full Text] [Related]
5. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA.
Tursz T; Brouet JC; Flandrin G; Danon F; Clauvel JP; Seligmann M
Am J Med; 1977 Oct; 63(4):499-502. PubMed ID: 410294
[TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
8. [Sarcomatous and leukemic forms of Waldenström's macroglobulinemia].
Dao C; Zittoun R; Diebold J; Cadiou M; Reynes M; Gaudric M; Tricot G; Bousser J
Sem Hop; 1975 Dec; 51(48):2935-42. PubMed ID: 175505
[TBL] [Abstract][Full Text] [Related]
9. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal IgM with anti-muscle tissue activity in a patient with Waldenström's macroglobulinaemia: secretion of identical immunoglobulin by the established lymphoid cell line.
Micouin C; Seigneurin JM; Renversez JC; Roussel B; Favre M; Leroux D
Clin Exp Immunol; 1984 Dec; 58(3):677-84. PubMed ID: 6096055
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
[TBL] [Abstract][Full Text] [Related]
13. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Naderi N; Yang DT
Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.
Mailankody S; Landgren O
Best Pract Res Clin Haematol; 2016 Jun; 29(2):187-193. PubMed ID: 27825465
[TBL] [Abstract][Full Text] [Related]
15. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
16. [Anti-smooth-muscle antibody activity of monoclonal IgM in Waldenström's disease].
Krulik M; Vittecoq D; Abuaf N; Genot JY; Homberg JC; Debray J
Sem Hop; 1983 Jun; 59(23):1737-41. PubMed ID: 6308799
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
Jalali S; Ansell SM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
[TBL] [Abstract][Full Text] [Related]
18. [Myelopathy manifesting as macroglobulinemia].
Woimant F; Schanen A; Bertail MA; Dupuy M; Lecoz P; Haguenau M; Pépin B
Ann Med Interne (Paris); 1985; 136(2):121-4. PubMed ID: 3935023
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenström's macroglobulinemia.
Haraguchi S; Tomiyoshi Y; Aoki S; Sakemi T
Nephron; 2002 Oct; 92(2):452-5. PubMed ID: 12218329
[TBL] [Abstract][Full Text] [Related]
20. Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenström's macroglobulinemia.
Fine JM; Lambin P; Massari M; Leroux P
Acta Med Scand; 1982 May; 211(3):237-9. PubMed ID: 6805257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
